Previous Article | Next Article ![]()
Molecular and Cellular Biology, December 2001, p. 7971-7980, Vol. 21, No. 23
Harvard-MIT Division of Health Sciences and
Technology, Massachusetts Institute of Technology, Cambridge,
Massachusetts 02139
Received 4 May 2001/Returned for modification 6 June 2001/Accepted 27 August 2001
Cytoplasmic stresses, including heat shock, osmotic stress, and
oxidative stress, cause rapid inhibition of protein synthesis in cells
through phosphorylation of eukaryotic initiation factor 2 Protein synthesis in intact
reticulocytes and their lysates is dependent on the availability of
heme. In heme deficiency, protein synthesis is inhibited, with a marked
decrease in the formation of 40S-eukaryotic initiation factor 2 (eIF2)-Met-tRNAf GTP (43S preinitiation complex)
and with increased phosphorylation of the Phosphorylation of eIF2 In addition to the stress conditions described above, there are other
environmental stresses that are known to induce rapid inhibition of
translation in the cell through eIF2 The production of HRI knockout mice in our laboratory (14)
enables us to determine the role of HRI in these stress
responses. This work was performed using mouse reticulocytes and
nucleated erythroid progenitor cells from fetal livers. Since HRI is
most abundant in erythroid cells, these cells are most suitable for studying the functions of HRI. Furthermore, reticulocytes have been
used classically as a model system for studying translation, since they
have no nuclei and therefore no transcriptional regulation, which can
also affect protein output.
We report here, for the first time, the presence of HRI in nucleated
erythroid progenitor cells. In addition, in both reticulocytes and
fetal liver erythroid progenitor cells, HRI is activated by various
cytoplasmic stresses, including arsenite treatment, heat shock, and
osmotic shock, but not by ER stress or nutrition starvation. Most
importantly, our results demonstrate that HRI is the only eIF2 Materials.
[35S]methionine (3,000 Ci/mmol) and [ Preparation of mouse reticulocytes.
Wild-type, HRI knockout,
and PKR knockout mice were injected with phenylhydrazine at 40 mg/kg on
days 0, 1, and 3 to induce hemolysis, subsequent erythropoiesis, and
release of reticulocytes into the bloodstream. Blood samples were
collected by heart puncture at day 7, and the percentages of
reticulocytes in the peripheral blood were determined by new
methylene blue staining. The percentages of reticulocytes were between
85 and 95%.
Stress challenge of reticulocytes.
The blood samples were
washed twice with ice-cold phosphate-buffered saline supplemented with
5 mM glucose and resuspended in Dulbecco modified Eagle medium
with 2% dialyzed fetal bovine serum at a concentration of
108 reticulocytes/ml. The cells were plated onto
six-well plates (108/well) and preincubated for
30 min at 37°C in a tissue culture incubator for recovery. The cells
were then subjected to different stresses: (i) heat shock at 42°C for
30 min, (ii) sodium arsenite at various concentrations and time periods
as indicated in the figures, (iii) osmotic shock with 0.5 M NaCl for
1 h, and (iv) Thapsigargin (Tg) (1 to 20 µM) for ER stress for
1 h. For nutrient starvation, the reticulocytes were washed three
times with either serum-free or methionine-free medium and maintained
in these media for 1 h for serum or amino acid starvation. In
examining the chaperone antagonists and reducing reagent, the cells
were pretreated with GA (4 to 40 µg/ml), CIA (5 to 40 mM), and NAC (5 to 20 mM) for 30 min before the stress challenges. For protein
synthesis, cells were pulse-labeled with 100 µCi of
[35S]methionine in low-methionine medium
(containing 1/10 of the methionine concentration of the complete
medium) for 30 min after the stress challenge.
Preparation and stress challenge of mouse fetal liver cells.
Embryonic livers at day 14.5 from both wild-type and
HRI Lysate preparation and Western blot analysis.
For Western
blotting, the cells were lysed in sodium dodecyl sulfate (SDS) sample
buffer by adding 1/3 volume of 4× SDS sample buffer directly into cell
suspensions. The samples were then boiled for 3 min and loaded onto
SDS-polyacrylamide gels (7% for HRI and 12% for eIF2 Immunoprecipitation (IP) and kinase assays.
Cells
(108) were lysed in 500 µl of cell lysis buffer
(20 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1 mM
Na2EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM
sodium pyrophosphate, 1 mM Tetracycline-inducible expression of HRI in CHO cells.
The
cDNAs of both the wild type and an inactive mutant of HRI (K196R HRI)
were put into the pCDNA4/TO vector with the tetracycline-inducible promoter (Invitrogen). The plasmid DNAs were transfected into the
Chinese hamster ovary (CHO)-TRX cell line (Invitrogen), and stable cell
lines were established by selection of the cells with both Zeocin and
Blasticidin. Expression of HRI and its mutant was induced with 1 µg
of tetracycline per ml for 24 h. Cells were then treated with
arsenite at 100 µM for 1 h. Cells were washed once with cold
phosphate-buffered saline and lysed in SDS sample buffer. The
expression and activation of HRI were detected by Western blot analysis
as described above.
Activation of HRI by arsenite treatment.
To characterize the
role of HRI in the inhibition of translation in response to arsenite
treatment, reticulocytes were produced by treating mice with
phenylhydrazine as described in Materials and Methods. Cells were
washed, incubated in culture medium, and then treated with various
concentrations of sodium arsenite for 60 min or with 200 µM arsenite
for different time periods. Protein synthesis was measured by the
incorporation of [35S]methionine into the
globin chains. Arsenite treatment shut off globin synthesis completely
in these cells, since no detectable [35S]methionine incorporation into globins was
observed in the arsenite-treated cells (Fig.
1A). Arsenite has been shown to induce
eIF2
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.23.7971-7980.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Translation Initiation Control by
Heme-Regulated Eukaryotic Initiation Factor 2
Kinase in
Erythroid Cells under Cytoplasmic Stresses

![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
(eIF2
)
by eIF2
kinases. We have investigated the role of heme-regulated
inhibitor (HRI), a heme-regulated eIF2
kinase, in stress
responses of erythroid cells. We have demonstrated that HRI in
reticulocytes and fetal liver nucleated erythroid progenitors is
activated by oxidative stress induced by arsenite, heat shock, and
osmotic stress but not by endoplasmic reticulum stress or nutrient
starvation. While autophosphorylation is essential for the activation
of HRI, the phosphorylation status of HRI activated by different
stresses is different. The contributions of HRI in various stress
responses were assessed with the aid of HRI-null reticulocytes
and fetal liver erythroid cells. HRI is the only eIF2
kinase
activated by arsenite in erythroid cells, since HRI-null cells do not
induce eIF2
phosphorylation upon arsenite treatment. HRI is also the
major eIF2
kinase responsible for the increased eIF2
phosphorylation upon heat shock in erythroid cells. Activation of HRI
by these stresses is independent of heme and requires the presence of
intact cells. Both hsp90 and hsc70 are necessary for all stress-induced
HRI activation. However, reactive oxygen species are involved only in
HRI activation by arsenite. Our results provide evidence for a novel
function of HRI in stress responses other than heme deficiency.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
subunit of eIF2. eIF2 is
an initiation factor which binds GTP and
Met-tRNAf and is required for the formation of
the 43S initiation complex. The phosphorylation of eIF2
in heme
deficiency is the result of the activation of heme-regulated inhibitor
(HRI), which is a heme-regulated eIF2
kinase (8, 9).
The mechanism of inhibition of translation initiation by the
phosphorylation of eIF2
has been studied extensively (18,
19). In brief, the recycling of eIF2 in initiation requires the
exchange of bound GDP for GTP. Under physiological conditions, eIF2 has
a 400-fold-greater affinity for GDP than for GTP. The exchange of
tightly bound GDP for GTP requires eIF2B, which is rate limiting and is
present at 15 to 25% of the amount of eIF2. When eIF2
is
phosphorylated, the binding of eIF2(
P)-GDP to the regulatory
subcomplex of eIF2B is much tighter than the binding of eIF2-GDP to
eIF2B (25). This tighter interaction of phosphorylated
eIF2 with eIF2B prevents the GDP-GTP exchange activity of eIF2B. In
this manner, once the amount of phosphorylated eIF2 exceeds the amount
of eIF2B, the shutoff of protein synthesis occurs.
was later found to be a common regulatory
mechanism of protein translation under various stress conditions and is
carried out by the family of eIF2
kinases. In addition to HRI, there
are three other known eIF2
kinases at present. They are the
interferon-induced double-stranded RNA (dsRNA)-dependent eIF2
kinase
(PKR), the GCN2 protein kinase, and the recently identified mammalian
endoplasmic reticulum (ER) resident kinase (PERK), which is identical
to PEK that is highly expressed in the pancreas (17, 38).
These eIF2
kinases share extensive homology in their kinase
catalytic domains and phosphorylate eIF2
at the serine 51 residue
(reviewed in reference 23). However, the regulatory
domains and the regulatory mechanism of each of these eIF2
kinases
are very different. PKR is regulated by dsRNA through two N-terminal
dsRNA-binding domains and is activated by dsRNA upon viral infection
(reviewed in reference 33). GCN2 is activated under the
condition of amino acid starvation through the C-terminal domain, which
contains a His-tRNA synthase-like sequence (3, 20, 40).
PERK is essential for ER stress and is activated by ER stress through
its luminal domain, which is similar to the sensor domain of the
ER-stress kinase Irel (16, 17, 38). HRI is regulated by
heme through the two heme-binding domains in the N terminus and kinase
insert domain (6, 34).
phosphorylation. These include
heat shock, arsenite treatment, osmotic stress, and nutrient starvation
(4). It remains to be determined which eIF2
kinase(s)
is activated under these stresses. Recently, the availabilities of
cells lacking PKR or PERK have been useful in addressing this question.
It has been shown that PERK is essential for ER stress but not for
cytoplasmic stresses such as arsenite or heat shock (16,
17). PKR is dispensable for either essential amino acid
starvation or ER stress (17, 24).
kinase that is activated by arsenite treatment of erythroid cells, as
HRI
/
cells fail to increase eIF2
phosphorylation upon arsenite treatment. These results underscore the
importance of HRI in stresses other than heme deficiency, particularly
the oxidative stress induced by arsenite.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-32P]ATP (3,000 Ci/mmol) were
purchased from New England Technologies Inc. Sodium arsenite, N-acetyl-L-cysteine (NAC), and
clofibric acid (CIA) were from Sigma, and geldanamycin (GA) was from
Calbiochem. The anti-PKR antibody was from Santa Cruz, and the
anti-phosphorylated-eIF2
antibody was from Biosource International Inc.
/
mice were excised and dispersed by being
passed through a 21-gauge needle in Dulbecco modified Eagle medium with
2% fetal bovine serum. A single-cell suspension was preincubated in
this culture medium for recovery for at least 45 min. The cells were
used for stress response study as described above for reticulocytes.
P and total
eIF2
). Western blot analyses for HRI and eIF2
were carried out as
described previously (2).
-glycerophosphate, 1 mM
Na3VO4, 1 mM NaF, 1 µM
aprotinin, 1 µM leupeptin, 5 µM pepstatin A, and 1 mM
phenylmethylsulfonyl fluoride) at 4°C for 15 min. Cell debris were
removed by centrifugation at 10,000 × g for 5 min at 4°C. Cell
lysates from equal numbers of cells (107) were
mixed with anti-mouse HRI antiserum (14) or anti-PKR polyclonal antibody and incubated at 4°C for 2 h. Protein
A-Sepharose beads (50 µl) were then added, and the samples were
incubated at 4°C overnight with rocking. The Sepharose immunocomplex
was washed five times with 1 ml of wash solution (50 mM Tris-HCl [pH 7.4], 50 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1%
Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM
-glycerophosphate, 1 mM Na3VO4, 1 mM NaF, and
protease inhibitors). After the last wash, the Sepharose beads were
resuspended in 20 µl of 2× kinase assay buffer (40 mM Tris-HCl [pH
8.0], 4 mM MgCl2, and 0.2 mM EDTA). eIF2
kinase assays were then performed by the addition of 3.5 µl of
labeling mix (0.5 µl of 10 mM ATP, 5 µCi of
[
-32P]ATP, and 200 ng of the recombinant
yeast eIF2
) at 30°C for 5 min for HRI or 20 min for PKR. The
reactions were terminated by the addition of 10 µl of 3× SDS sample
buffer. The extent of eIF2
phosphorylation was visualized by
autoradiography after SDS-polyacrylamide gel electrophoresis
(SDS-PAGE).
![]()
RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
phosphorylation in NIH 3T3 cells (30). The
extent of eIF2
phosphorylation in arsenite-treated reticulocytes was
examined by Western blot analysis using anti-phospho-eIF2
antibody.
As shown in Fig. 1A, there was a pronounced increase in eIF2
phosphorylation in the reticulocytes upon arsenite treatment, while the
amount of total eIF2
remained constant.

View larger version (44K):
[in a new window]
FIG. 1.
Activation of HRI by arsenite in mouse reticulocytes.
(A) Effect of arsenite concentration on activation of HRI. Mouse
reticulocytes were isolated as described in Materials and
Methods. After recovery, the cells were treated with 100, 200, or 400 µM arsenite (As) or 1 µM Tg for 30 min and then labeled with
[35S]methionine for an additional 30 min. Total cellular
proteins were then separated by SDS-PAGE. The incorporation of
[35S]methionine into globins was detected by exposing the
nitrocellulose membrane to X-ray film. The extents of HRI activation
and eIF2
phosphorylation were detected with anti-mouse HRI antibody
and anti-eIF2
P antibody. Total eIF2
was determined with
anti-eIF2
monoclonal antibody. The upshifted species of HRI are
indicated by an arrow. C, control. (B) Time course of HRI
activation by arsenite. Mouse reticulocytes were treated with 200 µM
arsenite for different time periods as indicated. (C) Kinase activity
of HRI. HRI in reticulocytes was immunoprecipitated from lysates of
arsenite-treated, Tg-treated, or control reticulocytes with anti-HRI
antibody, and the kinase activities were assayed in vitro by using
recombinant yeast eIF2
as a substrate. The incorporation of
32P into eIF2
was detected by autoradiography. In lanes
7 and 8, the reticulocyte lysates from the control cells were either
treated in vitro with 50 µM arsenite or heat shocked (hs) at 42°C
for 30 min prior to immunoprecipitation. (D) Heme-independent
activation of HRI by arsenite. Reticulocytes were treated with or
without hemin (H, 40 µM) for 1 h prior to arsenite treatment
(200 µM, 1 h).
kinase
activity and also for the proper conformation for HRI to remain in a
soluble state (2). The hyperphosphorylation of HRI upon
arsenite treatment was accompanied by an increase of its eIF2
kinase
activity as demonstrated by in vitro kinase assays of
immunoprecipitated HRI (Fig. 1C, lanes 2 to 4). In addition, treatment
of reticulocyte lysates in vitro with arsenite or heat shock (Fig. 1C,
lanes 7 and 8) failed to activate HRI. These results indicate that the
activation of HRI by arsenite and heat shock requires the presence of
the intact reticulocytes. The activation of HRI by arsenite suggests
that there is an additional function of HRI in cytoplasmic stress
responses besides heme deficiency. Additionally, as shown in Fig. 1D,
the activation of HRI by arsenite was not affected by pretreatment of
the cells with hemin (40 µM), which prevented the activation of HRI
in control cells. This result indicates that the mechanism of HRI
activation by arsenite is different from that of heme deficiency.
Tg is known to induce ER stress and specifically activates PERK to
phosphorylate eIF2
(17). As expected, HRI was not
activated by Tg (Fig. 1A and C, lanes 5). This is consistent with the
fact that PERK is the eIF2
kinase responsible for the ER stress
response (15, 16). Most interestingly, there was neither
increased eIF2
phosphorylation nor inhibition of globin synthesis in
the Tg-treated reticulocytes. The same results were obtained when higher concentrations of Tg (up to 20 µM) were used. These
concentrations of Tg were sufficient to induce eIF2
phosphorylation
in both NIH 3T3 and mouse embryonic fibroblast (MEF) cells (data not
shown). Thus, there is no ER stress response in the reticulocytes,
which is consistent with the fact that reticulocytes do not produce a
significant amount of secretory proteins.
Activation of HRI by various cytoplasmic stresses in reticulocytes
and nucleated erythroid progenitor cells.
Since HRI is activated
by arsenite but not by Tg, the question whether HRI can also be
activated by other cytoplasmic stresses was examined. Reticulocytes and
fetal liver erythroid cells were subjected to different stress
conditions as described in Materials and Methods. Activation of HRI in
reticulocytes detected by electrophoretic mobility shift was observed
under heat shock and osmotic stress, with corresponding increases of
eIF2
phosphorylation and inhibition of globin synthesis under these
conditions (Fig. 2A and B). However, HRI
was not activated under amino acid starvation or serum starvation (Fig.
2B and C). The increases in eIF2
P in vivo were quantitated from
Western blot signals from three separate experiments; there was a
three- to fourfold-higher eIF2
P level in reticulocytes under these
stress conditions (Fig. 2B). Although this method of detection does not
allow estimation of the percentage of eIF2
phosphorylated, it is
useful and adequate for determining the relative extents of eIF2
phosphorylation under different conditions.
|
kinase assays of immunoprecipitated HRI, as shown in Fig.
2C. The eIF2
kinase assays were performed in the linear range of the
time course and HRI concentrations (data not shown). The increase in
eIF2
P observed using the immunoprecipitated HRI was more modest than
that observed in vivo (Fig. 2B). The reason for this is likely due to
the activation of latent HRI by the removal of the heme during IP.
Nonetheless, the results of IP-coupled eIF2
kinase assays did show
the activation of HRI by arsenite, heat shock, and osmotic shock, in
contrast to the lack of activation of HRI in nutrient starvation. These
results indicated that HRI is a stress-activated kinase in response to several cytoplasmic stress conditions other than heme deficiency, which
has been well characterized.
Interestingly, although HRI is activated by many stresses, the
mechanisms of activation may be different, since activated HRI migrated
differently in the SDS-PAGE. It is believed that arsenite is able to
mimic most of the effects of heat shock, including inhibition of
protein synthesis, induction of heat shock proteins, and activation of
stress-activated kinases. However, we found that the upshift of HRI in
SDS-PAGE caused by arsenite treatment was greater than that produced by
heat shock (Fig. 2B). This observation suggests that arsenite induces a
more extensive phosphorylation per HRI molecule and implies that
mechanisms of activation of HRI by these two stress conditions may
differ. However, definitive proof for different mechanisms of
activation by different stress responses will require the actual
identification of the phosphorylation sites. Osmotic shock-activated
HRI migrated similarly to heat shock-activated HRI.
There are several different modifications that may alter the migration
of a protein in SDS-PAGE, including proteolysis, deamidation, glycosylation, or phosphorylation. In order to demonstrate that the
mobility shift of HRI upon activation is due to different extents of
phosphorylation, the control and stressed reticulocyte lysates were
treated with alkaline phosphatase. As shown in Fig. 2D, alkaline
phosphatase treatment of the lysates converted all of the upshifted
active HRI back to the fastest-migrating form. Thus, these upshifted
species of HRI are the result of multiple phosphorylation of HRI. This
conclusion is confirmed by our observation using the K196R mutant HRI,
which undergoes autophosphorylation extremely poorly (2,
7). As shown in Fig. 2E, both wild-type and K196R mutant HRI
were expressed in CHO cells upon induction with tetracycline. In
response to arsenite treatment, wild-type HRI expressed in CHO cells
was upshifted as in reticulocytes and fetal liver cells. In contrast,
the K196R mutant HRI did not upshift upon arsenite treatment. Thus,
autophosphorylation is required for the formation of the upshifted
species of HRI upon stress.
The same stress experiments were carried out in mouse fetal liver
nucleated erythroid cells. As shown in Fig.
3, HRI is also present in fetal liver
erythroid progenitor cells and displayed multiple phosphorylated
species as in reticulocytes. Similar to that in reticulocytes, HRI was
activated by arsenite treatment (Fig. 3A) and by heat shock and osmotic
stress (Fig. 3B) but not by ER stress, amino acid starvation, or serum
starvation (Fig. 3B and C). One difference between reticulocytes and
fetal liver cells is that there was increased eIF2
phosphorylation
under amino acid or serum starvation in fetal liver cells even though HRI was not activated. The reason for this difference might be due to
the absence of GCN2 in highly differentiated reticulocytes.
|
HRI is the only eIF2
kinase activated by arsenite in erythroid
cells.
As described above, HRI can be activated by cytoplasmic
stresses such as arsenite treatment, heat shock, and osmotic stress. It
remains to be determined how important HRI is in these stress responses. Is HRI the only eIF2
kinase responsible for these stresses? Other eIF2
kinase, especially PKR, are known to be present
in reticulocytes and may also be involved in these stress responses.
PKR
/
reticulocytes and
HRI
/
reticulocytes and fetal liver cells were
used to address this question. Arsenite treatment with either different
concentrations (Fig. 3A and 4A) or
different time periods (data not shown) failed to increase eIF2
phosphorylation in HRI
/
cells. Furthermore,
arsenite treatment resulted in the inhibition of protein synthesis in
HRI+/+, but not HRI
/
,
fetal liver cells (Fig. 3D). This result demonstrates that HRI is the
only eIF2
kinase activated in erythroid cells upon arsenite treatment. In contrast, increased eIF2
phosphorylation was still observed in HRI
/
reticulocytes and fetal
liver cells under other stresses, such as heat shock and osmotic stress
(Fig. 3B and 4A). Thus, even though HRI is activated by these stresses,
it is not the only eIF2
kinase responsible for increased eIF2
phosphorylation under stress. Other eIF2
kinases may be activated
and are also involved in heat shock and osmotic stress responses.
However, HRI is the predominant eIF2
kinase activated in heat shock,
since the extent of eIF2
phosphorylation was significantly reduced
in HRI
/
cells compared to in wild-type cells.
In osmotic stress, other eIF2
kinase members or phosphatases
contribute more significantly, since no significant difference in
eIF2
phosphorylation was observed between wild-type and
HRI
/
cells.
|
/
reticulocytes, the eIF2
phosphorylation pattern of the stressed
PKR
/
reticulocytes was nearly identical to
that of wild-type cells (Fig. 4A). The activity of PKR was also
measured by IP-coupled protein kinase assays. There was no
detectable PKR activation upon introduction of these cytoplasmic
stresses, while PKR was activated by dsRNA as expected (Fig. 4B). Thus,
PKR is not essential for stress responses induced by arsenite, heat
shock, or osmotic stress in reticulocytes. Collectively, these results
demonstrate that HRI is the eIF2
kinase responsible for
arsenite-induced eIF2
phosphorylation and is also the main one for
the heat shock response in reticulocytes and fetal liver cells.
Role of ROS in stress-induced activation of HRI. Stress-activated signaling cascades may be mediated by an altered redox potential in the cell during oxidative stress. The key contributors to altered redox potential are reactive oxygen species (ROS), which are formed in most cases by extracellular stress conditions. Arsenite is thought to be an oxidative stress inducer and can cause increases of intracellular ROS (10). Arsenite activation of HRI was found to occur only in intact reticulocytes and not in reticulocyte lysates (Fig. 1C). Thus, arsenite does not act directly on HRI.
The possibility of ROS involvement in HRI activation under different stresses was examined by using the reducing reagent NAC. NAC is a thiol-containing antioxidant capable of directly inactivating ROS as well as inducing glutathione production and thus blocks ROS-mediated signal transduction. Reticulocytes were pretreated with NAC for 30 min before being subjected to different stresses. The phosphorylation of eIF2
and the activation of HRI in these cells were then analyzed.
Our results showed that pretreatment with NAC (20 mM) prevented the
activation of HRI by arsenite with a concomitant decrease in eIF2
phosphorylation (Fig. 5). NAC had no
effect on the activation of HRI by heat shock or osmotic stress (Fig.
5). NAC by itself also had no significant effect on the activity of HRI
in untreated cells (Fig. 5). These results indicate the involvement of
ROS in HRI activation upon arsenite treatment but not in heat shock or
osmotic stress. We can also conclude that HRI can be activated through
pathways other than ROS, as in the cases of heat shock and osmotic
shock.
|
Role of heat shock protein chaperones in HRI activation under
stress conditions.
Both hsp90 and hsc70 have been shown to
interact and regulate HRI activity in vitro (41, 42). We
have examined the possible involvement of these two chaperones in the
activation of HRI in intact reticulocytes upon stress. Reticulocytes
were pretreated with GA, a specific inhibitor of hsp90
(29), or with CIA, an hsc70 antagonist (42),
for 30 min prior to arsenite treatment. Our results demonstrate that
the activation of HRI by arsenite is prevented by GA or CIA in a
dose-dependent manner with a concomitant decrease of eIF2
phosphorylation (Fig. 6). CIA or GA alone
had no significant effect on HRI activation or eIF2
P. Similar
results were observed under heat shock and osmotic stress. Thus, these results strongly suggest that hsp90 and hsc70 are required for the
activation of HRI by cytoplasmic stresses in intact reticulocytes.
|
| |
DISCUSSION |
|---|
|
|
|---|
It has been well established that HRI is activated in heme
deficiency of reticulocytes (reviewed in reference 8). Our
recent study of HRI
/
mice demonstrates the
physiological function of HRI in balancing globin synthesis with the
availability of heme (14). However, it remains to be
determined whether HRI also plays a role in regulating protein
synthesis under other stress conditions. Here, we report a novel
function of HRI in response to cytoplasmic stresses other than heme
deficiency in both reticulocytes and immature nucleated erythroid
cells. By using HRI
/
reticulocytes and fetal
liver erythroid progenitor cells, we demonstrate that HRI is the only
eIF2
kinase activated by arsenite in erythroid cells and is
responsible for the increased eIF2
phosphorylation caused by
arsenite treatment in these cells.
It has been speculated for some time about which eIF2
kinase family
member is responsible for the increased eIF2
phosphorylation and the
subsequent inhibition of protein synthesis caused by cytoplasmic stresses such as arsenite treatment, heat shock, and osmotic stress (4). Among the four known eIF2
kinases, PERK is not
activated by either arsenite or heat shock (17). GCN2 was
originally discovered in yeast and is activated during amino acid
starvation (20). It was later also found in
Drosophila, mouse, and human (3, 40). It has
been reported that GCN2 can also be activated by glucose starvation
(43) or serum starvation (3). To date, the
contribution of GCN2 to arsenite treatment and other cytoplasmic stresses is still unknown. Our present study indicates that GCN2 is not
likely to be activated by arsenite. As shown in Fig. 3, both wild-type
and HRI
/
fetal liver cells responded to amino
acid and serum starvation, indicating the presence of functional GCN2.
However, HRI
/
fetal liver cells failed to
respond to arsenite despite the response to amino acid and serum starvation.
In nonerythroid cells, PKR is likely the eIF2
kinase activated by
arsenite, since little or no HRI is expressed in nonerythroid cells
(13). It has been reported that PKR is activated by
arsenite in murine interleukin-3-dependent NFS/N1.H7 cells
(21) and NIH 3T3 and MEF cells (30). In
addition PKR-null MEF cells are more resistant to arsenite-induced
apoptosis (30). Recently, a cellular protein activator of
PKR was cloned from human (PACT) (31) and mouse (RAX)
(21). PACT/RAX is a dsRNA-binding protein, forms a
heterodimer with PKR through its dsRNA-binding motifs, and activates PKR in vitro in the absence of dsRNA (21, 31). Arsenite
treatment induces rapid phosphorylation of PACT/RAX and the association with PKR (30). However, we found here that PKR is not
essential for arsenite-induced eIF2
phosphorylation in reticulocytes
(Fig. 4A) and is not activated by arsenite in mouse erythroid cells as
examined by IP-coupled protein kinase assays (Fig. 4B). One reason for
this is that the activator of PKR, PACT/RAX, may be lacking or unable
to be phosphorylated in erythroid cells upon stress. Therefore, PKR
cannot be activated by arsenite in erythroid cells.
Since both PKR and HRI can be activated by various stresses, the
involvement of these two eIF2
kinases seems to depend on the
tissue-specific expression of these kinases. In erythroid cells, HRI is
the most predominant eIF2
kinase and is responsible for the
phosphorylation of eIF2
by arsenite and most other cytoplasmic stresses. In nonerythroid cells like NIH 3T3 and MEF cells, it is
likely that PKR is activated by these stresses, since there is little
to no HRI in these cells. Our results also indicate that ER stress and
amino acid starvation are unique to PERK and GCN2, respectively. These
stresses do not activate HRI (Fig. 1, 2, and 3). Similarly, it has been
shown recently that PKR is dispensable for ER stress and amino acid
starvation (24). The possible role of GCN2 in cytoplasmic
stress remains to be investigated when GCN2
/
cells are available.
In the case of high-salt osmotic stress, the response is different from
that to either arsenite or heat shock. There is no significant
reduction of eIF2
P in either HRI
/
or
PKR
/
reticulocytes. It is possible that GCN2
or PERK may be another eIF2
kinase responding to osmotic stress.
Unlike the regulation of HRI by heme, which binds directly to HRI and inhibits its activity, activation of HRI by arsenite treatment or heat shock is independent of heme. This conclusion is supported by two different experimental approaches. One of them is heme reversibility. Activation of HRI in heme deficiency in intact reticulocytes can be prevented by adding heme to the cells (14) (Fig. 1D), while arsenite activation of HRI cannot be suppressed by addition of hemin (Fig. 1D). This result indicates that the mechanisms of HRI activation by heme deficiency and arsenite treatment differ. The other supporting evidence is provided by the requirement of the intact living cells for the activation of HRI by arsenite and heat shock but not by heme deficiency. Once reticulocytes were lysed, HRI could not be activated by treatment with arsenite or heat shock (Fig. 1C). Thus, activation of HRI by arsenite is indirect and requires other components of the living cell. Furthermore, the difference in mechanisms of HRI activation by arsenite and heme deficiency is also indicated by the different phosphorylation statuses of HRI under these conditions. The upshift of HRI in SDS-PAGE caused by arsenite treatment, heat shock, and osmotic stress is higher than that caused by heme deficiency (data not shown).
A model summarizing stress activation of eIF2
kinases in erythroid
cells is shown in Fig. 7. Under stress
conditions, HRI serves a major role in regulating protein synthesis in
erythroid cells. It can be activated by several different stresses
other than heme deficiency. Activation of HRI by heme deficiency occurs intracellularly, while activation by other stresses requires the presence of the intact cells. Arsenite-induced eIF2
phosphorylation is mediated exclusively through the activation of HRI, while increased eIF2
phosphorylation under osmotic stress or heat shock is mediated through activation of both HRI and other eIF2
kinases or through the
inhibition of phosphatases. HRI contributes more significantly under
heat shock than under osmotic stress. The mechanism of the activation
of HRI by arsenite is different from that of activation by heat shock
or osmotic shock. ROS are involved in the signaling of arsenite
activation of HRI only. Furthermore, HRI activated by arsenite is
hyperphosphorylated compared to HRI activated by heat shock or osmotic
shock. HRI is not activated by nutrient starvation or by ER stress in
either reticulocytes or fetal liver erythroid progenitor cells.
|
Both arsenite treatment and heat shock are known to activate the
mitogen-activated protein (MAP) kinases, including ERKs, p38, and JNKs
(32). The MAP kinase pathway is also important for
activation of many signaling targets, which lead to modification of
transcriptional factors and translational regulators (27). We have found that ERKs, JNKs, and p38 were expressed and were activated by arsenite in fetal liver cells (data not shown). However, we found that the ERK inhibitor PD98059 (27) and the p38
inhibitor SB203580 (36) had no significant effect on HRI
activation and eIF2
phosphorylation in fetal liver cells or
reticulocytes (data not shown). Similarly, we found that staurosporine,
which is known to inhibit all MAP kinases but not eIF2
kinases
(26), had no significant effect on HRI activation either
(data not shown). Thus, it appears that the activation of HRI by
stresses does not require the activation of MAP kinases.
Stress-activated signaling cascades can be affected by altered redox potential in the cell. ROS are a key contributor to altered redox potential (reviewed in reference 35). Arsenite can cause the formation of ROS and is thus thought to be an oxidative stress inducer (10). ROS are considered to be the primary intracellular change that serves as an important cellular component linking external stimuli with signal transduction. ROS can modulate signaling molecules, including both kinases and transcription factors. One of the most well-known targets of ROS is the stress-activated kinase (1). In this study, we also found that HRI activation by arsenite depends on ROS formation in the cell. ROS can modulate signaling molecules through two different means (37). One is to oxidize the cysteine of the target proteins directly and alter conformation and activity. The other is through cysteine-rich, redox-sensitive proteins such as thioredoxin and glutathione. It remains to be determined how ROS regulate the activity of HRI. However, it seems likely that glutathione acts as a mediator. The translation rate in rabbit reticulocyte lysates can be inhibited by GSSG (the oxidized form of glutathione) through the activation of HRI (11, 22).
The chaperone hsp90 is known to be a kinase chaperone, as it binds to various kinases and regulates their activities (5). Its role in the folding and maturation of newly synthesized HRI has been demonstrated in rabbit reticulocyte lysates (41). We show here that hsp90 is also essential for HRI activation under stress conditions. The mechanism by which hsp90 works in this process is still not clear. Both the nonactivated form and stress-activated hyperphosphorylated forms of HRI can be coimmunoprecipitated with hsp90 (data not shown).
The role of hsc70 in HRI regulation seems to be more complicated. A dual role of hsc70 in HRI regulation has been suggested by Uma et al. (42). Their in vitro study using rabbit reticulocyte lysates indicates that hsc70 is required for the folding and transformation of HRI into an active kinase and is subsequently required to negatively attenuate the activation of transformed HRI. Disruption of Hsc70 function by CIA in heme-deficient reticulocyte lysates resulted in the hyperactivation of HRI. However, this is not the case in intact reticulocytes. Treatment of reticulocytes with CIA alone did not cause the activation of HRI. Under cytoplasmic stress induced by arsenite, heat shock, and osmotic stress, CIA inhibits the stress-induced activation of HRI. Thus, in living cells, hsc70 is essential for HRI activation by stresses.
Contamination of drinking water with arsenic compounds poses an important health hazard. Long-term arsenic exposure can lead to many kinds of cancers, such as lung, bladder, and skin cancers, as well as to defects in erythropoiesis (28, 39). We have shown that HRI is involved in the regulation of erythroid cell proliferation (12). Our recent work on HRI knockout mice also indicates an essential role of HRI in stress-induced erythropoiesis (14). The unique role of HRI in the arsenite response and the availability of the HRI knockout mice generated in our laboratory provide us important tools to elucidate the molecular mechanisms of how arsenite affects erythropoiesis.
In summary, we have discovered a new function of HRI in erythroid cells
under cytoplasmic stress responses other than heme deficiency. We also
demonstrated the essential role of HRI in arsenite-induced eIF2
phosphorylation and inhibition of protein synthesis in erythroid cells.
| |
ACKNOWLEDGMENT |
|---|
This work was supported by Public Health Service grant DK-16272 to J.-J.C. from the National Institute of Diabetes and Digestive and Kidney Diseases.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: E25-545, Massachusetts Institute of Technology, 77 Massachusetts Ave., Cambridge, MA 02139. Phone: (617) 253-9674. Fax: (617) 253-3459. E-mail: j-jchen{at}mit.edu.
Present address: Department of Cancer Immunology and AIDS,
Dana-Farber Cancer Institute, Boston, MA 02115.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Adler, V., Z. Yin, K. D. Tew, and Z. Ronai. 1999. Role of redox potential and reactive oxygen species in stress signaling. Oncogene 18:6104-6111[CrossRef][Medline]. |
| 2. | Bauer, B. N., M. Rafie-Kolpin, L. Lu, A. Han, and
J.-J. Chen. Multiple autophosphorylation is
essential for the formation of the active and stable homodimer of
heme-regulated eIF-2 kinase. Biochemistry, in press.
|
| 3. | Berlanga, J. J., J. Santoyo, and C. DeHaro. 1999. Characterization of a mammalian homolog of the GCN2 eukaryotic initiation factor 2alpha kinase. Eur. J. Biochem. 265:754-762[Medline]. |
| 4. | Brostrom, C. O., and M. A. Brostrom. 1998. Regulation of translational initiation during cellular responses to stress. Prog. Nucleic Acid Res. Mol. Biol. 58:79-125[Medline]. |
| 5. | Caplan, A. J. 1999. Hsp90's secrets unfold: new insights from structural and functional studies. Trends Cell. Biol. 9:262-268[CrossRef][Medline]. |
| 6. |
Chefalo, P.,
J. Oh,
M. Rafie-Kolpin, and J.-J. Chen.
1998.
Heme-regulated eIF-2 kinase purifies as a hemoprotein.
Eur. J. Biochem.
258:820-830[Medline].
|
| 7. |
Chefalo, P. J.,
J. M. Yang,
K. V. A. Ramaiah,
L. Gehrke, and J.-J. Chen.
1994.
Inhibition of protein synthesis in insect cells by baculovirus-expressed heme-regulated eIF-2 kinase.
J. Biol. Chem.
269:25788-25794 |
| 8. |
Chen, J.-J.
2000.
Heme-regulated eIF-2 kinase, p. 529-546.
In
N. Sonenberg, J. W. B. Hershey, and M. B. Mathews (ed.), Translational control of gene expression Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 9. |
Chen, J.-J., and I. M. London.
1995.
Regulation of protein synthesis by heme-regulated eIF-2 kinase.
Trends Biochem. Sci.
20:105-108[CrossRef][Medline].
|
| 10. | Chen, Y. C., S. Y. Lin-Shiau, and J. K. Lin. 1998. Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis. J. Cell. Physiol. 177:324-333[CrossRef][Medline]. |
| 11. |
Clemens, M. J.,
B. Safer,
W. C. Merrick,
W. F. Anderson, and I. M. London.
1975.
Inhibition of protein synthesis in rabbit reticulocyte lysates by double-stranded RNA and oxidized glutathione: indirect mode of action on polypeptide chain initiation.
Proc. Natl. Acad. Sci. USA
72:1286-1290 |
| 12. |
Crosby, J. S.,
P. J. Chefalo,
I. Yeh,
S. Ying,
I. M. London,
P. Leboulch, and J.-J. Chen.
2000.
Regulation of hemoglobin synthesis and proliferation of differentiating erythroid cells by heme-regulated eIF-2 kinase.
Blood
96:3241-3247 |
| 13. |
Crosby, J. S.,
K. Lee,
I. M. London, and J.-J. Chen.
1994.
Erythroid expression of the heme-regulated eIF-2 kinase.
Mol. Cell. Biol.
14:3906-3914 |
| 14. | Han, A., C. Yu, L. Lu, Y. Fujiwara, C. Browne, G. Chin, M. Fleming, P. Leboulch, S. H. Orkin, and J.-J. Chen. HRI is required for translational regulation and survival of erythroid precursors in iron-deficiency. EMBO J., in press. |
| 15. |
Harding, H. P.,
H. Zeng,
Y. Zhang,
R. Jungries,
P. Chung,
H. Plesken,
D. D. Sabatini, and D. Ron.
2001.
Diabetes mellitus and exocrine pancreatic dysfunction in perk / mice reveals a role for translational control in secretory cell survival.
Mol. Cell
7:1153-1163[CrossRef][Medline].
|
| 16. | Harding, H. P., Y. Zhang, A. Bertolotti, H. Zeng, and D. Ron. 2000. Perk is essential for translational regulation and cell survival during the unfolded protein response. Mol. Cell 5:897-904[CrossRef][Medline]. |
| 17. | Harding, H. P., Y. Zhang, and D. Ron. 1999. Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 397:271-274[CrossRef][Medline]. |
| 18. | Hershey, J. W., and W. C. Merrick. 2000. Pathway and mechanism of initiation of protein synthesis, p. 33-88. In N. Sonenberg, J. W. Hershey, and M. Matthews (ed.), Translational control of gene expression. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 19. | Hershey, J. W. B. 1991. Translational control in mammalian cells. Annu. Rev. Biochem. 60:717-755[CrossRef][Medline]. |
| 20. | Hinnebusch, A. G. 1996. Translational control of GCN4: gene-specific regulation by phosphorylation of eIF2, p. 199-244. In J. W. B. Hershey, M. B. Mathews, and N. Sonenberg (ed.), Translational control. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 21. |
Ito, T.,
M. Yang, and W. S. May.
1999.
RAX, a cellular activator for double-stranded RNA-dependent protein kinase during stress signaling.
J. Biol. Chem.
274:15427-15432 |
| 22. |
Kan, B.,
I. M. London, and D. H. Levin.
1988.
Role of reversing factor in the inhibition of protein synthesis initiation by oxidized glutathione.
J. Biol. Chem.
263:15652-15656 |
| 23. |
Kaufman, R. J.
1999.
Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls.
Genes Dev.
13:1211-1233 |
| 24. | Kimball, S. R., M. J. Clemens, V. J. Tilleray, R. C. Wek, R. L. Horetsky, and L. S. Jefferson. 2001. The double-stranded RNA-activated protein kinase PKR is dispensable for regulation of translation initiation in response to either calcium mobilization from the endoplasmic reticulum or essential amino acid starvation. Biochem. Biophys. Res. Commun. 280:293-300[CrossRef][Medline]. |
| 25. |
Krishnamoorthy, T.,
G. D. Pavitt,
F. Zhang,
T. E. Dever, and A. G. Hinnebusch.
2001.
Tight binding of the phosphorylated alpha subunit of initiation factor 2 (eIF2alpha) to the regulatory subunits of guanine nucleotide exchange factor eIF2B is required for inhibition of translation initiation.
Mol. Cell. Biol
21:5018-5030 |
| 26. | Martin de la Vega, C., A. Garcia, M. E. Martin, A. Alcazar, O. Marin, C. Quevedo, and M. Salinas. 1999. Resistance of initiation factor 2. (eIF-2alpha) kinases to staurosporine: an approach for assaying the kinases in crude extracts. Cell Signal 11:399-404[CrossRef][Medline]. |
| 27. |
Morley, S. J., and L. McKendrick.
1997.
Involvement of stress-activated protein kinase and p38/ERK mitogen-activated protein kinase signaling pathways in the enhanced phosphorylation of initiation factor 4E in NIH 3T3 cells.
J. Biol. Chem.
272:17887-17893 |
| 28. | Morse, B. S., M. Conlan, D. G. Giuliani, and M. Nussbaum. 1980. Mechanism of arsenic-induced inhibition of erythropoiesis in mice. Am. J. Hematol. 8:273-280[Medline]. |
| 29. | Neckers, L., T. W. Schulte, and E. Mimnaugh. 1999. Geldanamycin as a potential anti-cancer agent: its molecular target and biochemical activity. Invest. New Drugs 17:361-373[CrossRef][Medline]. |
| 30. |
Patel, C. V.,
I. Handy,
T. Goldsmith, and R. C. Patel.
2000.
PACT, a stress-modulated cellular activator of interferon-induced double-stranded RNA-activated protein kinase, PKR.
J. Biol. Chem.
275:37993-37998 |
| 31. | Patel, R. C., and G. C. Sen. 1998. PACT, a protein activator of the interferon-induced protein kinase, PKR. EMBO J. 17:4379-4390[CrossRef][Medline]. |
| 32. | Porter, A. C., G. R. Fanger, and R. R. Vaillancourt. 1999. Signal transduction pathways regulated by arsenate and arsenite. Oncogene 18:794-802. |
| 33. | Proud, C. G. 1995. PKR: a new name and new roles. Trends Biochem. Sci. 20:241-246[CrossRef][Medline]. |
| 34. |
Rafie-Kolpin, M.,
P. J. Chefalo,
Z. Hussain,
J. Hahn,
S. Ma,
R. L. Matts, and J.-J. Chen.
2000.
Two heme-binding domains of heme-regulated eukaryotic initiation factor-2alpha kinase. N terminus and kinase insertion.
J. Biol. Chem.
275:5171-5178 |
| 35. |
Ronai, Z.
1999.
Deciphering the mammalian stress response a stressful task.
Oncogene
18:6084-6086[CrossRef][Medline].
|
| 36. |
Saklatvala, J.,
L. Rawlinson,
R. J. Waller,
S. Sarsfield,
J. C. Lee,
L. F. Morton,
M. J. Barnes, and R. W. Farndale.
1996.
Role for p38 mitogen-activated protein kinase in platelet aggregation caused by collagen or a thromboxane analogue.
J. Biol. Chem.
271:6586-6589 |
| 37. | Sen, C. 1998. Redox signaling and the emerging therapeutic potential of thiol antioxidants. Biochem. Pharmacol. 55:1747-1758[CrossRef][Medline]. |
| 38. |
Shi, Y.,
K. M. Vattem,
R. Sood,
J. An,
J. Liang,
L. Stramm, and R. C. Wek.
1998.
Identification and characterization of pancreatic eukaryotic initiation factor 2 -subunit kinase, PEK, involved in translational control.
Mol. Cell. Biol.
18:7499-7509 |
| 39. | Smith, A. H., E. O. Lingas, and M. Rahman. 2000. Contamination of drinking-water by arsenic in Bangladesh: a public health emergency. Bull. W. H. O. 78:1093-1103[Medline]. |
| 40. |
Sood, R.,
A. C. Porter,
D. Olsen,
D. R. Cavener, and R. C. Wek.
2000.
A mammalian homologue of GCN2 protein kinase important for translational control by phosphorylation of eukaryotic initiation factor-2 .
Genetics
154:787-801 |
| 41. |
Uma, S.,
S. D. Hartson,
J.-J. Chen, and R. L. Matts.
1997.
Hsp90 is obligatory for the heme-regulated eIF-2 kinase to acquire and maintain an activatable conformation.
J. Biol. Chem.
272:11648-11656 |
| 42. |
Uma, S.,
V. Thulasiraman, and R. L. Matts.
1999.
Dual role for Hsc70 in the biogenesis and regulation of the heme-regulated kinase of the subunit of eukaryotic translation initiation factor 2.
Mol. Cell. Biol.
19:5861-5871 |
| 43. |
Yang, R.,
S. A. Wek, and R. C. Wek.
2000.
Glucose limitation induces GCN4 translation by activation of Gcn2 protein kinase.
Mol. Cell. Biol.
20:2706-2717 |
This article has been cited by other articles: